The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 19, 2018
Filed:
Nov. 29, 2016
Applicant:
Santen Pharmaceutical Co., Ltd., Osaka-shi, Osaka, JP;
Inventors:
Kazutaka Kido, Ikoma, JP;
Takashi Nagano, Ikoma, JP;
Assignee:
SANTEN PHARMACEUTICAL CO., LTD., Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7048 (2006.01); A61K 9/00 (2006.01); A61K 47/06 (2006.01); A61K 47/14 (2017.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 9/10 (2013.01); A61K 31/7048 (2013.01); A61K 47/06 (2013.01); A61K 47/14 (2013.01); A61K 47/38 (2013.01);
Abstract
The objective of the present invention is to provide a new medicinal use of clarithromycin. The present invention is a therapeutic agent or a preventive agent for meibomian gland dysfunction or meibomian gland blockage and comprises clarithromycin as an active ingredient. The dosage form is preferably an eye drop or eye ointment.
Kido, Kazutaka. (2018). Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage (U.S. Patent No. 9999594). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9999594
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile